J Konieczny Selected Research

Muscle Rigidity

1/2009	N-oleoyl-dopamine decreases muscle rigidity induced by reserpine in rats.
2/2007	An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
9/2005	MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
1/2002	The role of striatal metabotropic glutamate receptors in Parkinson's disease.
9/2001	Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats.
8/2001	SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
1/2000	The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Konieczny Research Topics

Disease

7	Muscle Rigidity 01/2009 - 01/2000
6	Parkinson Disease (Parkinson's Disease) 06/2016 - 01/2000
6	Catalepsy 01/2009 - 09/2001
1	Neuroblastoma 07/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2013
1	Hyperthermia 09/2003

Drug/Important Bio-Agent (IBA)

8	Haloperidol (Haldol)FDA LinkGeneric 01/2009 - 01/2000
3	Dopamine (Intropin)FDA LinkGeneric 06/2016 - 01/2002
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 03/2007 - 01/2000
2	lactacystinIBA 06/2016 - 07/2013
2	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2016 - 07/2013
2	Reserpine (Serpasil)FDA Link 01/2009 - 08/2001
2	1-aminocyclopentane-1,2,4-tricarboxylic acidIBA 03/2007 - 02/2007
2	metabotropic glutamate receptor type 1IBA 02/2007 - 01/2002
1	UbiquitinIBA 06/2016
1	RotenoneIBA 07/2013
1	Proteasome InhibitorsIBA 07/2013
1	Biological ProductsIBA 01/2009
1	N-oleoyldopamineIBA 01/2009
1	proenkephalinIBA 03/2007
1	preproenkephalinIBA 03/2007
1	AcidsIBA 03/2007
1	Messenger RNA (mRNA)IBA 03/2007
1	metabotropic glutamate receptor 8IBA 02/2007
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2007
1	Methamphetamine (Desoxyn)FDA LinkGeneric 09/2003
1	4- (4- (4- chlorophenyl)- 4- hydroxy- 1- piperidinyl)- 1- (4- fluorophenyl)- 1- butanolIBA 01/2002
1	4-aminopyrrolidine-2,4-dicarboxylic acidIBA 01/2002
1	Adenosine (Adenocard)FDA LinkGeneric 08/2001
1	Levodopa (L Dopa)FDA LinkGeneric 08/2001
1	alpha-Methyltyrosine (Metirosine)FDA Link 08/2001
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 08/2001
1	Purinergic P1 Receptor AntagonistsIBA 08/2001
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2000
1	LigandsIBA 01/2000
1	eglumetadIBA 01/2000

Therapy/Procedure

1	Injections 01/2002
1	Therapeutics 01/2000